SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-23-008917
Filing Date
2023-12-18
Accepted
2023-12-18 17:18:54
Documents
1
Period of Report
2023-12-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3824
  Complete submission text file 0001683168-23-008917.txt   5413
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address TAVOR BUILDING, SHAAR YOKNEAM POB 533 YOKNEAM L3 2069206
Business Address
Mizrahy Moshe (Reporting) CIK: 0001803068 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37937 | Film No.: 231494756